The role of suPAR in kidney diseases

Journal Title: Annales Academiae Medicae Silesiensis - Year 2017, Vol 71, Issue

Abstract

Chronic kidney disease (CKD) is unquestionably a problem of social significance because it affects about 10% of the population. There is a search for biomarkers which could help select persons out of such a large group of patients with a high risk of disease progression and of its complications. The major cause of death in patients with end-stage renal disease are cardiovascular diseases. Accelerated atherosclerosis in this group of patients is associated with a chronic inflammatory state. The new biological marker of inflammation suPAR (soluble urokinase-type plasminogen activator receptor), is the focus of attention of the authors of this report. The relationship of suPAR with urinary tract infections and focal segmental glomerulosclerosis is also very interesting from the clinical perspective. The perception of suPAR as a blood circulating factor, inducing FSGS, throws new light on the pathomechanism of this medical condition, while unveiling promising therapeutic perspectives. A better understanding of the pathogenesis of the diseases discussed will help to reduce the unacceptably high mortality rate in patients with CKD. At present, common assaying of suPAR is not yet possible in the context of the above-mentioned issues. Nevertheless, studies are ongoing which may explain the still unclear issues concerning the relationship of the biomarker with the mentioned kidney diseases. Perhaps, follo-wing their results suPAR assays may in the near future become routine diagnostics means in selected kidney diseases.

Authors and Affiliations

Beata Łącka-Gaździk, Mirosław Śnit, Magdalena Żak-Lenart, Władysław Grzeszczak

Keywords

Related Articles

Is there a link between the gene polymorphisms of the vitamin D receptor [rs731236, rs1544410 and rs7975232] with overweight and abdominal obesity?

INTRODUCTION: Among the most common causes of overweight and abdominal abdominal obesity, environmental factors and genetic factors are mentioned. The role of the genetic factors involved in the pathogenesis of abdominal...

Znaczenie polimorfizmu rs1137100 LEPR w rozwoju nadwagi i otyłości w badanej populacji

WSTĘP: Nadwaga i otyłość stały się w obecnych czasach poważnym problemem zdrowia publicznego. Patogenezę tych schorzeń można wiązać m.in. z hormonem tkankowym – leptyną, a także jej receptorem kodowanym przez gen LEPR. R...

Acyl-CoA type 5 gene polymorphism and inappropriate body mass occurrence related to waist circumference and insulin resistance index among the population living in southern Poland

INTRODUCTION: Lipid metabolism disorders and the obesity connected with them are problems which occur increasingly more frequently in highly-developed countries. Acyl-CoA synthetase (ACSL) is an important enzyme in lipi...

Choroba zwyrodnieniowa stawów w praktyce lekarza rodzinnego

Celem pracy było zebranie najistotniejszych z punktu widzenia lekarza rodzinnego wiadomości dotyczących ChZS, by w swojej praktyce mógł on, współpracując z lekarzami innych dziedzin, poprowadzić pacjenta we wstępnej diag...

Application of radiotherapy and stereotactic radiosurgery in treatment of patients with brain gliosarcoma – preliminary results

AIM The aim of the work is to evaluate the results of the treatment of gliosarcoma according to the applied therapeutic methods. MATERIAL AND METHODS 43 patients (15 women and 28 men) aged 21 to 80 years were treated for...

Download PDF file
  • EP ID EP360074
  • DOI 10.18794/aams/65841
  • Views 115
  • Downloads 0

How To Cite

Beata Łącka-Gaździk, Mirosław Śnit, Magdalena Żak-Lenart, Władysław Grzeszczak (2017). The role of suPAR in kidney diseases. Annales Academiae Medicae Silesiensis, 71(), 265-270. https://www.europub.co.uk/articles/-A-360074